Background The evidence-based recommendations in 2011 wound closure surgery was significantly shortened with NPWT state that a negative-pressure wound therapy (NPWT) may after revascularization by means of PTA in CLI patients. be considered as an advanced wound care therapy for lower Level of Evidence: Level IV, therapeutic study. limb ulceration after successful revascularization. Since the . . grade of recommendation was determined by six articles Keywords Critical limb ischemia Diabetes . . which did not study patients with similar wound severity to Negative-pressure wound therapy Peripheral arterialdisease critical limb ischemia (CLI), we investigated the patients with Hemodialysis similar one. Methods Of the 169 cases who were surgically treated for lower extremity wounds due to CLI between January 1, Introduction 2007, and December 31, 2013, nine cases satisfied the follow- ing criteria in our institute. There were patients on hemodial- In 2000, the V.A.C. (KCI San Antonio, USA) treatment system, ysis due to diabetic nephropathy among patients with CLI, a negative-pressure wound therapy (NPWT) device, obtained and percutaneous transluminal angioplasty (PTA) was per- approval by the Medicare public medical insurance system for formed. These patients had foot gangrene, underwent debride- use in the elderly and disabled in the USA .
European Journal of Plastic Surgery – Springer Journals
Published: Feb 27, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera